中国药物经济学2019，Vol.14Issue(6)：9-12,4.DOI:10.12010/j.issn.1673-5846.2019.06.002
中国特发性肺纤维化患者的直接经济负担
Direct Economic Burden of Idiopathic Pulmonary Fibrosis in China
XUAN Jian-Wei 1HAN Qian 1DAI Hua-Ping 1XIE Bing-Bing 1WU Feng-Bo 1LU Yong-Ji 1REN Mao-Dong 1ZHANG Yan-Jun 1FAN Feng 1KANG Hong-Ge 1DUAN Xiao-Tuo 1CHEN Rong-Chang 1LUO Qun1
作者信息
摘要
关键词
特发性肺纤维化/直接医疗费用/医疗资源利用分类
医药卫生引用本文复制引用
XUAN Jian-Wei,HAN Qian,DAI Hua-Ping,XIE Bing-Bing,WU Feng-Bo,LU Yong-Ji,REN Mao-Dong,ZHANG Yan-Jun,FAN Feng,KANG Hong-Ge,DUAN Xiao-Tuo,CHEN Rong-Chang,LUO Qun..中国特发性肺纤维化患者的直接经济负担[J].中国药物经济学,2019,14(6):9-12,4.
